Sabubo, Lynmar A.

HRN: 21-65-61  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/30/2022
08/05/2022
IV
1.5 G
Q6H
Acute Tonsillopharyngitis
Waiting Final Action 
08/01/2022
CIPROFLOXACIN 500MG (TAB)
08/01/2022
08/07/2022
PO
500mg
Q24
Typhoid Fever
08/02/2022
CEFTRIAXONE 1G (VIAL)
08/02/2022
08/08/2022
IV
1g
Q12
Typhoid Fever
Waiting Final Action 
08/02/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/02/2022
08/09/2022
IV
500mg
Q8
Amoebiasis
Waiting Final Action 
05/27/2023
CEFUROXIME 1.5GM (VIAL)
05/27/2023
05/28/2023
IV
1.5gm
Q8 3 DOSES
Elevated WBC
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: